TG Therapeutics Inc (TGTX)
17.76
-0.20
(-1.11%)
USD |
NASDAQ |
May 15, 15:31
TG Therapeutics Price: 17.76 for May 15, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 14, 2024 | 17.51 | 18.37 | 17.51 | 17.96 | 3.736M |
May 13, 2024 | 16.75 | 17.57 | 16.63 | 17.32 | 4.317M |
May 10, 2024 | 16.91 | 17.12 | 16.60 | 16.62 | 2.227M |
May 09, 2024 | 17.23 | 17.34 | 16.83 | 16.92 | 2.679M |
May 08, 2024 | 16.99 | 17.63 | 16.98 | 17.12 | 4.231M |
May 07, 2024 | 16.50 | 17.28 | 16.42 | 17.18 | 4.532M |
May 06, 2024 | 16.26 | 16.63 | 15.76 | 16.51 | 3.778M |
May 03, 2024 | 16.75 | 17.00 | 15.96 | 16.19 | 4.804M |
May 02, 2024 | 16.20 | 16.76 | 15.55 | 16.42 | 8.549M |
May 01, 2024 | 17.15 | 18.00 | 14.87 | 15.88 | 18.59M |
Apr 30, 2024 | 13.30 | 13.75 | 12.93 | 13.66 | 5.207M |
Apr 29, 2024 | 13.66 | 13.85 | 13.22 | 13.32 | 2.880M |
Apr 26, 2024 | 13.94 | 14.00 | 13.41 | 13.47 | 2.841M |
Apr 25, 2024 | 13.56 | 13.99 | 13.29 | 13.91 | 3.860M |
Apr 24, 2024 | 14.28 | 14.35 | 13.74 | 13.98 | 2.725M |
Apr 23, 2024 | 14.17 | 14.56 | 14.17 | 14.25 | 3.223M |
Apr 22, 2024 | 13.95 | 14.31 | 13.66 | 14.10 | 2.274M |
Apr 19, 2024 | 13.87 | 14.02 | 13.26 | 13.78 | 3.666M |
Apr 18, 2024 | 13.99 | 14.63 | 13.85 | 13.99 | 3.484M |
Apr 17, 2024 | 14.06 | 14.14 | 13.55 | 13.82 | 3.077M |
Apr 16, 2024 | 13.98 | 14.17 | 13.76 | 14.00 | 1.615M |
Apr 15, 2024 | 14.15 | 14.58 | 13.94 | 14.07 | 2.269M |
Apr 12, 2024 | 14.76 | 14.87 | 13.91 | 14.16 | 3.881M |
Apr 11, 2024 | 14.81 | 14.99 | 14.58 | 14.76 | 2.242M |
Apr 10, 2024 | 14.56 | 15.06 | 14.44 | 14.71 | 2.985M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.74
Minimum
Jun 16 2022
54.90
Maximum
Dec 21 2020
18.45
Average
15.06
Median
Price Benchmarks
Amicus Therapeutics Inc | 9.655 |
Geron Corp | 3.865 |
Editas Medicine Inc | 5.96 |
G1 Therapeutics Inc | 4.705 |
Mersana Therapeutics Inc | 2.555 |
Price Related Metrics
PE Ratio | 80.73 |
PS Ratio | 9.204 |
Price to Book Value | 17.14 |
Price to Free Cash Flow | 131.30 |
Earnings Yield | 1.24% |
Market Cap | 2.745B |
Operating PE Ratio | 55.07 |
Normalized PE Ratio | 80.73 |